Solid tumor testing is a medical diagnostic procedure that involves analyzing a sample of a solid mass (tumor) taken from a patient to determine the presence and characteristics of cancerous cells. This testing can help diagnose the type of cancer and inform treatment decisions. The sample is typically obtained through a biopsy procedure and is then examined in a laboratory using techniques such as histology, cytology, or molecular testing. The results of solid tumor testing can be used to guide the selection of appropriate cancer therapies and monitor the effectiveness of treatment.
Allied Market Research has published a study report with the title Solid Tumor Testing Market ๐๐ข๐ณ๐ ๐ฐ๐๐ฌ ๐๐๐ฅ๐ฎ๐๐ ๐๐ญ ๐๐๐ ๐๐.๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐๐๐๐ ๐๐ง๐ ๐ข๐ฌ ๐๐ซ๐จ๐ฃ๐๐๐ญ๐๐ ๐ญ๐จ ๐๐๐ซ๐ง๐๐ซ ๐๐๐ ๐๐.๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐, ๐ซ๐๐ ๐ข๐ฌ๐ญ๐๐ซ๐ข๐ง๐ ๐ ๐๐๐๐ ๐จ๐ ๐.๐% ๐๐ซ๐จ๐ฆ ๐๐๐๐ ๐ญ๐จ ๐๐๐๐. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.
๐๐จ๐ฏ๐ข๐-๐๐ ๐๐๐๐ง๐๐ซ๐ข๐จ:
โข The outbreak of the COVID-19 pandemic had a negative impact on the growth of the global solid tumor testing market, as a huge number of medical colleges and hospitals across the globe were reconstructed to increase hospital capacity for patients diagnosed with COVID-19.
โข The pandemic negatively altered the way cancer patients are being diagnosed and treated in the near term. For instance, according to a review article by the National library of medicine published in 2020, it is estimated that as a result of COVID-19, screenings for cancers of the breast, colon, and cervix have dropped by 94%, 86%, and 94% between January 20, 2020, and April 21, 2020, respectively.
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐ซ๐๐ฉ๐ก๐ฌ ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ ๐๐๐ซ๐: https://www.alliedmarketresearch.com/request-sample/4501
๐๐ก๐๐ญ ๐๐ซ๐ ๐ญ๐ก๐ ๐๐๐๐ญ๐จ๐ซ๐ฌ ๐๐ซ๐ข๐ฏ๐ข๐ง๐ ๐ญ๐ก๐ ๐๐จ๐ฅ๐ข๐ ๐๐ฎ๐ฆ๐จ๐ซ ๐๐๐ฌ๐ญ๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ?
Rise in government funding for sepsis-related research activities and increase in the prevalence of infectious diseases drive the growth of the global sepsis diagnostic market. On the other hand, high costs associated with automated diagnostics devices impede the growth to some extent. However, developments in rapid diagnosis/point-of-care) techniques for early sepsis diagnostics are expected to create lucrative opportunities in the industry.
๐๐จ๐ฉ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐จ๐ ๐๐จ๐ฅ๐ข๐ ๐๐ฎ๐ฆ๐จ๐ซ ๐๐๐ฌ๐ญ๐ข๐ง๐
โข QIAGEN
โข QUEST DIAGNOSTICS INCORPORATED
โข Abbott Laboratories
โข Agilent Technologies Inc.
โข Biocare Medical LLC
โข F. Hoffmann-La Roche AG
โข ILLUMINA, INC.
โข MedGenome Labs Private Ltd
โข MYRIAD GENETICS, INC.
โข Thermo Fisher Scientific, Inc
๐๐จ๐ฅ๐ข๐ ๐๐ฎ๐ฆ๐จ๐ซ ๐๐๐ฌ๐ญ๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง: โ
The research provides detailed segmentation of the global solid tumor testing market based on type, application, end-user, and region. The report discusses segments and their sub-segments in detail with the help of tables and figures. Market players and investors can strategize according to the highest revenue-generating and fastest-growing segments mentioned in the report.
Based on type, the genetic testing segment held the highest share in 2021, accounting for nearly two-thirds of the global solid tumor testing market, and is expected to continue its leadership status during the forecast period. Moreover, the same segment is expected to register the highest CAGR of 7.3% from 2022 to 2031.
Based on application, the melanoma segment accounted for the highest share in 2021, contributing to nearly one-fifths of the global solid tumor testing market, and is expected to maintain its lead in terms of revenue during the forecast period. However, the breast segment is expected to manifest the highest CAGR of 7.7% from 2022 to 2031.
Based on end-user, the hospital segment accounted for the highest share in 2021, holding nearly one-third of the global solid tumor testing market, and is expected to continue its leadership status during the forecast period. However, the academic research institutions segment is estimated to grow at the highest CAGR of 7.2% during the forecast period.
Based on region, North America held the largest share in 2021, contributing to around two-fifths of the global solid tumor testing market share, and is projected to maintain its dominant share in terms of revenue in 2031. In addition, the Asia-Pacific region is expected to manifest the fastest CAGR of 8.3% during the forecast period. The research also analyzes regions including Europe and LAMEA.
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.alliedmarketresearch.com/purchase-enquiry/4501
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How big is the global & regional market in terms of revenue, sales and production?
- How far will the market grow in forecast period in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
- Which region has more opportunities?
By Region Outlook
โข North America
(U.S., Canada, Mexico)
โข Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
โข Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
โข LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.